Webinar: How to demonstrate foreign building compliance with drug good manufacturing practices (GUI-0080)
Drug Establishment Licensing Bulletin #191 August 21, 2025
On this page
Notification of webinar
On July 2, 2025, Health Canada posted How to demonstrate foreign building compliance with drug good manufacturing practices (GUI-0080) to the Health Canada website as described in DEL Bulletin 185.
We have pre-recorded a webinar to outline key changes to GUI-0080 and to provide you with contact information should you have any questions. This format has been chosen to provide flexibility in scheduling, and to allow you to proceed through the presentation at your own pace. The webinar will be available until October 24th, 2025.
Contact foreign.site-etranger@hc-sc.gc.ca for links to the webinar.
Contact us
Contact Health Canada's Health Product Inspection and Licensing Division by email:
- Submitting DEL applications: el.applications-le@hc-sc.gc.ca
- General DEL questions: del.questions-leppp@hc-sc.gc.ca
- Foreign building GMP evidence questions: foreign.site-etranger@hc-sc.gc.ca
- Domestic GMP questions: drug.gmp.questions-bpf.medicaments@hc-sc.gc.ca
- Active Pharmaceutical Ingredient (API) questions: api.questions-ipa@hc-sc.gc.ca